Oxyquinoline

Oxyquinoline

SCHEMBL1194584

[In+3].[O-]c1cccc2cccnc12.[O-]c1cccc2cccnc12.[O-]c1cccc2cccnc12

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.58
▸ LMNA P02545 3/20 0.58
▸ MMP2 P08253 2/20 0.58
▸ TSHR P16473 2/20 0.58
▸ CCR1 P32246 2/20 0.58
▸ CCR8 P51685 2/20 0.58
▸ MAPT P10636 2/20 0.58
▸ ALOX15 P16050 2/20 0.58
▸ HTT P42858 2/20 0.58
▸ GMNN O75496 1/20 0.58
▸ TP53 P04637 1/20 0.58
▸ HSP90AA1 P07900 1/20 0.58
▸ CYP3A4 P08684 1/20 0.58
▸ CYP2D6 P10635 1/20 0.58
▸ MMP9 P14780 1/20 0.58
▸ NFKB1 P19838 1/20 0.58
▸ MMP8 P22894 1/20 0.58
▸ THPO P40225 1/20 0.58
▸ MTOR P42345 1/20 0.58
▸ MMP13 P45452 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxyquinoline SCHEMBL952769 0.95 KDM4E (0.58) KDM4ELMNAMMP2TSHRCCR1
Oxyquinoline SCHEMBL4412189 0.95 KDM4E (0.58) KDM4ELMNAMMP2TSHRCCR1
Oxyquinoline SCHEMBL61235 0.95 KDM4E (0.58) KDM4ELMNAMMP2TSHRCCR1
Oxyquinoline SCHEMBL23091400 0.95 KDM4E (0.58) KDM4ELMNAMMP2TSHRCCR1
Oxyquinoline SCHEMBL460412 0.95 KDM4E (0.58) KDM4ELMNAMMP2TSHRCCR1
Oxyquinoline SCHEMBL23175212 0.95 KDM4E (0.58) KDM4ELMNAMMP2TSHRCCR1
Oxyquinoline SCHEMBL3357860 0.95 KDM4E (0.58) KDM4ELMNAMMP2TSHRCCR1
Oxyquinoline SCHEMBL166949 0.95 KDM4E (0.58) KDM4ELMNAMMP2TSHRCCR1
Oxyquinoline SCHEMBL22660883 0.95 KDM4E (0.58) KDM4ELMNAMMP2TSHRCCR1
Oxyquinoline SCHEMBL296880 0.95 KDM4E (0.58) KDM4ELMNAMMP2TSHRCCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6423429-B1 — — None — — US disclosed
CN-107849414-B Adhesive composition, adhesive film comprising the same, and organic electronic device comprising the same 株式会社LG化学 2020-06-05 — — CN disclosed
CN-107820512-B Adhesive film and organic electronic device including the same 株式会社LG化学 2020-05-19 — — CN disclosed
CN-107851731-B Organic electronic device 株式会社LG化学 2020-05-12 — — CN disclosed
EP-2265094-B1 LIGHT EMITTING ELEMENT AND DISPLAY PANEL PIONEER CORP (JP) 2020-01-22 — — EP disclosed
US-20190305249-A1 ORGANIC EL DISPLAY PROVIDED WITH GEL-STATE ENCAPSULANT INCORPORATING A DESICCANT AND A HIGH MOLECULAR-WEIGHT MEDIUM SAMSUNG DISPLAY CO LTD (KR) 2019-10-03 — — US disclosed
US-10326104-B2 Organic EL display provided with gel-state encapsulant incorporating a desiccant and a high molecular-weight medium SAMSUNG DISPLAY CO., LTD. (KR) 2019-06-18 — — US disclosed
US-10283568-B2 Light emitting apparatus having first luminous body and second luminous body PIONEER CORPORATION (JP) 2019-05-07 — — US disclosed
US-20180331321-A1 ORGANIC EL DISPLAY PROVIDED WITH GEL-STATE ENCAPSULANT INCORPORATING A DESICCANT AND A HIGH MOLECULAR-WEIGHT MEDIUM JAPAN DISPLAY INC. 2018-11-15 — — US disclosed
CN-105247702-B Organic electronic device 乐金显示有限公司 2018-10-26 — — CN disclosed
US-20050084707-A1 Organic electroluminescence device KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2005-04-21 — — US disclosed
US-20050003231-A1 El device NIPPON SODA CO., LTD. (JP) 2005-01-06 — — US disclosed
EP-1489154-A1 ORGANIC ELECTROLUMINESCENCE DEVICE Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) 2004-12-22 — — EP disclosed
EP-1486549-A1 ORGANIC ELECTROLUMINESCENT ELEMENT Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) 2004-12-15 — — EP disclosed
EP-1450588-A1 EL DEVICE NIPPON SODA CO., LTD. (JP) 2004-08-25 — — EP disclosed
US-6597109-B1 Electroluminescence apparatus comprising charge transfers compounds and electrode multilayers capable of preventing current leakage and having durability, high efficiency, brightness and displaying quality TDK CORPORATION (JP) 2003-07-22 — — US disclosed
US-6423429-B2 MADE BY CO-DEPOSITION OR SIMULTANEOUS EVAPORATION OF THE ORGANIC LAYER WITH A COMPOUND CAPABLE OF ACTING AS AN ELECTRON-ACCEPTING DOPANT; REDUCED ENERGY BARRIER IN THE HOLE INJECTION, LOW VOLTAGE CONSUMPTION REGARDLESS WORK FUNCTION Kido, Junji (JP) 2002-07-23 — — US disclosed
US-20010046611-A1 ORGANIC ELECTROLUMINESCENT DEVICES ROHM CO., LTD. (JP) 2001-11-29 — — US disclosed
EP-1030285-A1 DRIVER FOR ORGANIC EL DISPLAY AND DRIVING METHOD TDK Corporation (JP) 2000-08-23 — — EP disclosed
EP-0948063-A2 Organic electroluminescent devices Kido, Junji (JP) 1999-10-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050084707-A1 Organic electroluminescence device ELAVL1, SELE, CELF2 KDM4E 2019/4885LMNA 1262/4885MMP2 1799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback